Unicycive Therapeutics, Inc. Quarterly report [Sections 13 or 15(d)]

Quarterly report [Sections 13 or 15(d)]

Stockholders??? Equity (Deficit) (Details)

Stockholders’ Equity (Deficit) (Details) - USD ($)		1 Months Ended	3 Months Ended
Stockholders’ Equity (Deficit) (Details) - USD ($)	Jul. 11, 2023	Jul. 31, 2021	Jun. 30, 2025	Mar. 31, 2025	Feb. 18, 2025	Dec. 31, 2024	Dec. 19, 2024	Dec. 18, 2024	Dec. 11, 2024	Oct. 31, 2024	Oct. 09, 2024	Aug. 14, 2024	Jul. 29, 2024	Jul. 25, 2024	Jul. 23, 2024	Jul. 05, 2024	Jun. 25, 2024	Mar. 26, 2024	Mar. 13, 2024
Stockholders’ Equity (Deficit) [Line Items]
Common stock, shares authorized			400,000,000	400,000,000		400,000,000
Common stock, par value (in Dollars per share)			$ 0.001	$ 0.001		$ 0.001
Common stock share issued			14,111,852			11,384,236
Common stock price (in Dollars per share)		$ 50	$ 1,000
Shares of common stock	43,649		73,691
Convertible debt shares granted			18,419
Warrant [Member]
Stockholders’ Equity (Deficit) [Line Items]
Shares warrants		400,000
Common stock price (in Dollars per share)		$ 0.125
Warrants term		5 years	5 years
Exercise price per warrant (in Dollars per share)		$ 60	$ 60
Purchase of additional warrants		60,000
Proceeds of warrants (in Dollars)		$ 7,500
Series A-2 Preferred Stock [Member]
Stockholders’ Equity (Deficit) [Line Items]
Common stock share issued									462,455									285,000
Conversion of the shares series preferred stock	43,649								2,266.03						1,739.5			1,396.5
Series B Convertible Preferred Stock [Member]
Stockholders’ Equity (Deficit) [Line Items]
Common stock share issued																4,211,800
Series B-2 Preferred Stock [Member]
Stockholders’ Equity (Deficit) [Line Items]
Common stock share issued							300,300	144,100		43,800
Conversion of the shares series preferred stock							3,003	1,441		438						7,882
Series A-2 Prime Preferred Stock [Member]
Stockholders’ Equity (Deficit) [Line Items]
Common stock share issued					140,000						550,000	350,200	135,900	375,600	355,000		595,600
Conversion of the shares series preferred stock					686						2,695	1,715.98	665.91	1,840.44			2,918.44
IPO [Member]
Stockholders’ Equity (Deficit) [Line Items]
Common stock share issued		500,000
Common Stock [Member]
Stockholders’ Equity (Deficit) [Line Items]
Common stock price (in Dollars per share)		$ 49.9																	$ 1,000
Conversion of the shares series preferred stock	1,951,621